SequelSEC

FITLIFE BRANDS, INC. FTLF

Medicinal Chemicals & Botanical Products · CIK 0001374328 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$70.56M
Fiscal year ended 2025-09-30
Operating income
$10.68M
Fiscal year ended 2025-09-30
Free cash flow
$8.12M
Fiscal year ended 2025-09-30

FITLIFE BRANDS, INC. (FTLF) reported revenue of $70.56M and net income of $6.76M for the fiscal year ended 2025-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from FITLIFE BRANDS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Medicinal Chemicals & Botanical Products.

Income

FITLIFE BRANDS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Revenue$70.56M
Cost of revenue$41.84M
Gross profit$28.73M
Operating income$10.68M
Net income$6.76M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income$9.50M
Income tax expense$2.74M
Diluted EPSUnavailable
Selling, general & administrative$11.39M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

FITLIFE BRANDS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Cash & equivalentsUnavailable
Total assets$109.98M
Current assets$37.40M
Total liabilities$68.09M
Current liabilities$33.02M
Total equity incl. NCI$41.89M
Temporary (mezzanine) equityUnavailable
Inventory$22.23M
Accounts receivable$9.64M
Goodwill$19.37M
Long-term debt$32.36M
Accounts payable$9.15M

Cash flow

FITLIFE BRANDS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Operating cash flow$8.15M
Capital expenditures$37.00K
Investing cash flow-$42.54M
Financing cash flow$32.90M
Net change in cash-$1.21M
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$192.00K

Derived

FITLIFE BRANDS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-09-30
Free cash flow$8.12M
Gross margin40.7%
Operating margin15.1%
FCF margin11.5%
SBC / revenueUnavailable
Current ratio1.13x
Revenue YoY growth12.4%
Net margin9.6%
R&D / revenueUnavailable
CapEx / revenue0.1%
Long-term debt / equity0.77x
Effective tax rate28.9%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FTLF in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

AAWH ADIA AIBT BTMD CBDY CFOO CGC CHUC CRON CYAN DFTX HYEX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.